Misplaced Pages

Spasmodic dysphonia, also known as laryngeal dystonia, is a disorder in which the muscles that generate a person's voice go into periods of spasm. This results in breaks or interruptions in the voice, often every few sentences, which can make a person difficult to understand. The person's voice may also sound strained or they may be nearly unable to speak. Onset is often gradual and the condition is lifelong.

The cause is unknown. Risk factors may include family history. Triggers may include an upper respiratory infection, injury to the larynx, overuse of the voice, and psychological stress. The underlying mechanism is believed to typically involve the central nervous system, specifically the basal ganglia. Diagnosis is typically made following examination by a team of healthcare providers. It is a type of focal dystonia.

While there is no cure, treatment may improve symptoms. Most commonly this involves injecting botulinum toxin into the affected muscles of the larynx. This generally results in improvement for a few months. Other measures include voice therapy, counselling, and amplification devices. If this is not effective, surgery may be considered; while evidence to support surgery is limited, some have recovered following surgery.

The disorder affects an estimated 2 per 100,000 people. Women are more commonly affected. Onset is typically between the ages of 30 and 50. Severity is variable between people. In some, work and social life are affected. Life expectancy is, however, normal.

Signs and symptoms

Symptoms of spasmodic dysphonia can come on suddenly or gradually appear over the span of years. They can come and go for hours or even weeks at a time, or remain consistent. Gradual onset can begin with the manifestation of a hoarse voice quality, which may later transform into a voice quality described as strained with breaks in phonation. These phonation breaks have been compared to stuttering in the past, but there is a lack of research in support of spasmodic dysphonia being classified as a fluency disorder. It is commonly reported by people with spasmodic dysphonia that symptoms almost only occur on vocal sounds that require phonation. Symptoms are less likely to occur at rest, while whispering, or on speech sounds that do not require phonation. It is hypothesized this occurs because of an increase in sporadic, sudden, and prolonged tension found in the muscles around the larynx during phonation. This tension affects the abduction and adduction (opening and closing) of the vocal folds. Consequently, the vocal folds are unable to retain subglottal air pressure (required for phonation) and breaks in phonation can be heard throughout the speech of people with spasmodic dysphonia.

Regarding types of spasmodic dysphonia, the main characteristic of spasmodic dysphonia, breaks in phonation, is found along with other varying symptoms. The voice quality of adductor spasmodic dysphonia can be described as “strained-strangled” from tension in the glottal region. Voice quality for abductor spasmodic dysphonia can be described as breathy from variable widening of the glottal region. Vocal tremor may also be seen in spasmodic dysphonia. A mix and variance of these symptoms are found in mixed spasmodic dysphonia.

Symptoms of spasmodic dysphonia typically appear in middle-aged people, but have also been seen in people in their twenties, with symptoms emerging as young as teenage years.

Cause

Although the exact cause of spasmodic dysphonia is still unknown, epidemiological, genetic, and neurological pathogenic factors have been proposed in recent research.

Risk factors include:

• Being female
• Being middle aged
• Having a family history of neurological diseases (e.g., tremor, dystonia, meningitis, and other neurological diseases)
• Stressful events
• Upper respiratory tract infections
• Sinus and throat illnesses
• Heavy voice use
• Cervical dystonia
• Childhood measles or mumps
• Pregnancy and parturition

It has not been established whether these factors directly affect the development of spasmodic dysphonia (SD), however, these factors could be used to identify possible and/or at-risk patients.

Researchers have also explored the possibility of a genetic component to SD. Three genes have been identified that may be related to the development of focal or segmental dystonia: TUBB4A, THAP1, and TOR1A genes. However, a recent study that examined the mutation of these three genes in 86 SD patients found that only 2.3% of the patients had novel/rare variants in THAP1, but none in TUBB4A and TOR1A. Evidence of a genetic contribution for dystonia involving the larynx is still weak, and more research is needed in order to establish a causal relationship between SD and specific genes.

SD is a neurological disorder rather than a disorder of the larynx, and as in other forms of dystonia, interventions at the end organ (i.e., larynx) have not offered a definitive cure, only symptomatic relief. The pathophysiology underlying dystonia is becoming better understood as a result of discoveries about genetically based forms of the disorder, and this approach is the most promising avenue to a long-term solution.

SD is classified as a neurological disorder. However, because the voice can sound normal or near normal at times, some practitioners believe it to be psychogenic; that is, originating in the affected person's mind rather than from a physical cause. This was especially true in the 19th and 20th centuries. No medical organizations or groups take this position. A comparison of SD patients compared with vocal fold paralysis (VFP) patients found that 41.7% of the SD patients met the DSM-IV criteria for psychiatric comorbidity compared with 19.5% of the VFP group. However, another study found the opposite, with SD patients having significantly less psychiatric comorbidity compared to VFP patients: "The prevalence of major psychiatric cases varied considerably among the groups, from a low of seven percent (1/14) for spasmodic dysphonia, to 29.4 percent (5/17) for functional dysphonia, to a high of 63.6 percent (7/11) for vocal cord paralysis." A review in the journal Swiss Medicine Weekly states that "Psychogenic causes, a 'psychological disequilibrium', and an increased tension of the laryngeal muscles are presumed to be one end of the spectrum of possible factors leading to the development of the disorder”. Alternatively, many investigations into the condition feel that the psychiatric comorbidity associated with voice disorders is a result of the social isolation and anxiety that patients with these conditions feel as a consequence of their difficulty with speech, as opposed to the cause of their dysphonia. The opinion that SD is psychogenic is not upheld by experts in the scientific community.

SD is formally classified as a movement disorder; it is a type of focal dystonia known as laryngeal dystonia.

Diagnosis

Diagnosis of spasmodic dysphonia requires a multidisciplinary team and consideration of both perceptual and physiological factors. There is currently no universally accepted diagnostic test for spasmodic dysphonia, which presents a challenge for diagnosis. Additionally, diagnostic criteria have not been agreed upon as the distinguishing features of this disorder have not been well-characterized.

A team of professionals including a speech–language pathologist, an otolaryngologist, and a neurologist, are typically involved in spasmodic dysphonia assessment and diagnosis. The speech–language pathologist conducts a speech assessment including case history questions to gather information about voice use and symptoms. This is followed by clinical observation and perceptual rating of voice characteristics such as voice breaks or strain, which are selectively present in normal speech over other voice activities such as whispering or laughing. Symptoms also vary across types of spasmodic dysphonia. For example, voiced sounds are more affected in adductor spasmodic dysphonia, while unvoiced sounds are more affected in abductor spasmodic dysphonia. Following the speech assessment, the otolaryngologist conducts a flexible transnasal laryngoscopy to view the vocal folds and activity of the muscles controlling them in order to eliminate other possible causes of the voice disorder. In spasmodic dysphonia, producing long vowels or speaking sentences results in muscle spasms that are not observed during other vocal activities such as coughing, breathing, or whispering. To evaluate the individual for any other neurological problems, this examination is followed up with an assessment by the neurologist.

Voice quality symbol

The voice quality symbol for spasmodic dysphonia is ꟿ.

Differential diagnosis

Because spasmodic dysphonia shares many characteristics with other voice disorders, misdiagnosis frequently occurs. A common misdiagnosis is muscle tension dysphonia, a functional voice disorder that results from use of the voice, rather than a structural abnormality. Some parameters can help guide the clinician towards a decision. In muscle tension dysphonia, the vocal folds are typically hyperadducted in a constant way, not in a spasmodic way. Additionally, the voice difficulties found in spasmodic dysphonia can be task specific, as opposed to those found in muscle tension dysphonia. Being able to differentiate between muscle tension dysphonia and spasmodic dysphonia is important because muscle tension dysphonia typically responds well to behavioral voice treatment, but spasmodic dysphonia does not. This is crucial to avoid providing inappropriate treatment, but in some cases, a trial of behavioral voice treatment can also be helpful to establish a differential diagnosis.

Spasmodic dysphonia can also be misdiagnosed as voice tremor. The movements that are found in this disorder are typically rhythmic in nature, as opposed to the muscle spasms of spasmodic dysphonia. It is important to note that voice tremor and spasmodic dysphonia can co-occur in some patients.

Differential diagnosis is particularly important for determining appropriate interventions, as the type and cause of the disorder determine the most effective treatment. Differences in treatment effectiveness are present even between the types of spasmodic dysphonia. Diagnosis of spasmodic dysphonia is often delayed due to these challenges, which in turn presents difficulties in choosing the proper interventions.

Types

The three types of spasmodic dysphonia (SD) are adductor spasmodic dysphonia, abductor spasmodic dysphonia, and mixed spasmodic dysphonia. A fourth type called whispering dysphonia has also been proposed. Adductor spasmodic dysphonia is the most common type.

Adductor spasmodic dysphonia

Adductor spasmodic dysphonia (ADSD) is the most common type, affecting around 87% of individuals with SD. In ADSD, sudden involuntary muscle movements or spasms cause the vocal folds (or vocal cords) to squeeze together and stiffen. As the name suggests, these spasms occur in the adductor muscles of the vocal folds, specifically the thyroarytenoid and the lateral cricoarytenoid. These spasms make it difficult for the vocal folds to vibrate and produce voice. Words are often cut off or are difficult to start because of the muscle spasms. Therefore, speech may be choppy but differs from stuttering. The voice of an individual with adductor spasmodic dysphonia is commonly described as strained or strangled and full of effort. Surprisingly, the spasms are usually absent while laughing, speaking at a high pitch, or speaking while singing, but singers can experience a loss of range or the inability to produce certain notes of a scale or with projection. Stress, however, often makes the muscle spasms more severe.

Abductor spasmodic dysphonia

Abductor spasmodic dysphonia (ABSD) is the second most common type, affecting around 13% of individuals with SD. In ABSD, sudden involuntary muscle movements or spasms cause the vocal folds to open. As the name suggests, these spasms occur in the single abductor muscle of the vocal folds, called the posterior cricoarytenoid. The vocal folds cannot vibrate when they are open. The open position of the vocal folds also allows air to escape from the lungs during speech. As a result, the voices of these individuals often sound weak, quiet, and breathy or whispery. As with adductor spasmodic dysphonia, the spasms are often absent during activities such as laughing or singing, but singers can experience a loss of range or the inability to produce certain notes of a scale or with projection.

Mixed spasmodic dysphonia

Mixed spasmodic dysphonia is the most rare type. Mixed spasmodic dysphonia involves both muscles that open the vocal folds and those that close them and, therefore, has features of both adductor and abductor spasmodic dysphonia. Some researchers believe that a subset of cases classified as mixed spasmodic dysphonia may actually be ADSD or ABSD subtype with the addition of compensatory voice behaviors that make it appear mixed. This further adds to the difficulty in achieving accurate diagnosis.

Whispering dysphonia

A fourth type has also been described. This appears to be caused by mutations in the TUBB4 gene on the short arm of chromosome 19 (19p13.2–p13.3). This gene encodes a tubulin gene. The pathophysiology of this condition has yet to be determined.

Treatment

There are a number of potential treatments for spasmodic dysphonia, including Botox, voice therapy, and surgery. A number of medications have also been tried including anticholinergics (such as benztropine) which have been found to be effective in 40–50% of people, but which are associated with a number of side effects.

Botulinum toxin

Botulinum toxin (Botox) is often used to improve some symptoms of spasmodic dysphonia through weakening or paralyzing the vocal folds, thus preventing muscle spasms. The level of evidence for its use is currently limited; little is known about optimal dosage, frequency of injections, or exact location of injection. However, it remains a choice for many people due to the predictability and low chance of long term side effects. It results in periods of some improvement, with the duration of benefit lasting for 10–12 weeks on average before symptoms return to baseline. Repeat injection is required to sustain good vocal production, as results are only temporary. Some transient side effects observed in adductor spasmodic dysphonia include reduced speaking volume, difficulty swallowing, and a breathy and hoarse voice quality. While treatment outcomes are generally positive, it is presently unclear whether this treatment approach is more or less effective than others.

Voice therapy

Voice therapy appears to be ineffective in cases of true spasmodic dysphonia. However, as it is difficult to distinguish between spasmodic dysphonia and functional dysphonias, and misdiagnosis is relatively common, trial of voice therapy is often recommended before more invasive procedures are tried. Some also state that it is useful for mild symptoms and as an add-on to botox therapy and others report success in more severe cases. Laryngeal manual therapy, which is massaging of the neck and cervical structures, also shows positive results for intervention of functional dysphonia.

Surgery

If other measures are not effective, surgery may be considered; however, evidence to support surgery as a treatment for SD is limited. Treatment outcomes are generally positive, though more research is required to determine its effectiveness. Post-surgery voices can be imperfect and about 15% of people have significant difficulties. If symptoms do recur, this typically happens in the first 12 months. As of 2011, surgery was rarely used as a treatment approach for SD. Surgical approaches include recurrent laryngeal nerve resection, selective laryngeal adductor denervation-reinnervation (SLAD-R), thyroplasty, thyroarytenoid myectomy, and laryngeal nerve crush. Recurrent laryngeal nerve resection involves removing a section of the recurrent laryngeal nerve. Recurrent laryngeal nerve avulsion is a more drastic removal of sections of the nerve, and has positive outcomes of 80% at three years. SLAD-R is effective specifically for adductor spasmodic dysphonia, for which it has shown good outcomes in about 80% of people at 8 years. Thyroplasty changes the position or length of the vocal folds.

History

In 1871, Ludwig Traube coined the term 'Spastic Dysphonia' while writing a description of a patient who suffered from a nervous hoarseness.

In 1895, Johann Schnitzler used the term "Spastic Aphonia", which is now called abductor SD, and "Phonic Laryngeal Spasms", now called adductor SD.

Hermann Nothnagel followed by calling the condition "Coordinated Laryngeal Spasms", while Fraenkel coined the term "Mogiphonia" as a slowly developing disorder of the voice, in which is characterized by the increasing of vocal fatigue, the spasmodic constriction of the thorat muscles, and pain around the larynx. A comparison was made to "mogigraphia", which we now know as "Writer's Cramp".

In 1899, William Gowers described functional laryngeal spasms whereby the vocal cords were brought together with too much force while speaking. This was contrasted to Phonic Paralysis, where the speaker's vocal chords could not be brought together during the action of speech. He reported in agreement with Fraenkel, that the vocal symptoms are most closely compared to Writers Cramp. Gowers reported and described a case by Gerhardt, where the patient had suffered from Writer's Cramp, and had learned to play the flute at the age of 50. Blowing the flute caused laryngeal spasms and a voice sound unintended by the patient, accompanied by contractions of the arm and mouth.

This disorder was termed "Spastic Dysphonia", and as it was not a disorder with spasticity, was re-named to what is now called, "Spasmodic Dysphonia", by Arnold Aronson in 1968.

In earlier works, Aronson performed Minnesota Multiphasic Personality Inventory screening and helped to establish SD as not being a Psychiatric Disorder, after reviewing psychiatric interviews of SD patients. Aronson formally characterized the two types of SD, the adductor, and abductor forms. Aronson described that adductor SD suffered from decreased loudness, and a mono-tonality, with a choked, strain-strangled voice quality. A vocal tremor was also often heard with a slowed speech rate. this was compared to what is seen in Essential Tremor.

Initial surgical efforts to treat the condition were published in 1976 by Herbert Dedo and involved cutting of the recurrent laryngeal nerve.

Notable cases

• Scott Adams, creator of the comic strip Dilbert
• Johnny Bush, country and western musician and songwriter
• Keath Fraser, Canadian author who has documented the challenges and treatment of his condition in the book The Voice Gallery: Travels With a Glass Throat (2002)
• Chip Hanauer, American hydroplane racing driver
• Rodney Hicks, American Broadway, film, and TV performer
• Kaori, Japanese voice actor
• Robert F. Kennedy Jr., attorney, conspiracy theorist, and independent candidate for the 2024 United States presidential election
• Mary Lou Lord, indie folk musician
• Andy MacWilliams, radio broadcaster for the Cincinnati Stingers, Chicago Black Hawks, and Cincinnati Cyclones.
• Benny Martin (1928–2001), American bluegrass fiddler, affected from 1980 to 1997
• Darryl McDaniels of the rap group Run DMC
• Jenny Morris, New Zealand-born Australian pop, rock singer-songwriter
• Petra Pau, one of the vice presidents of the German Bundestag.
• Jeff Pegues, Chief National Affairs and Justice Correspondent at CBS News
• Diane Rehm, American public radio talk show host
• Aleesha Rome, causing her to quit her singing career.
• Gail Strickland, an American actress
• Mark Stuart, American Christian rock musician, of Audio Adrenaline
• Linda Thompson, British folk-rock musician

References

1. ^ "Spasmodic Dysphonia". NIDCD. 6 March 2017. Archived from the original on 4 July 2017. Retrieved 16 July 2017.
2. ^ "Laryngeal Dystonia". NORD (National Organization for Rare Disorders). 2017. Archived from the original on 16 November 2016. Retrieved 16 July 2017.
3. Murry T (November 2014). "Spasmodic dysphonia: let's look at that again". Journal of Voice. 28 (6): 694–9. doi:10.1016/j.jvoice.2014.03.007. PMID 24972536.
4. "'Dilbert' creator recovers from rare disorder". NBC News. 27 October 2006.
5. Albert ML, Knoefel JE (1994). Clinical Neurology of Aging. Oxford University Press. p. 512. ISBN 9780195071672.
6. ^ Colton, R. H., & Casper, J. K. (2006). Understanding voice problems: A physiological perspective for diagnosis and treatment. Baltimore, MD: Lippincott Williams & Wilkins.
7. ^ Cannito MP, Burch AR, Watts C, Rappold PW, Hood SB, Sherrard K (June 1997). "Disfluency in spasmodic dysphonia: a multivariate analysis". Journal of Speech, Language, and Hearing Research. 40 (3): 627–41. doi:10.1044/jslhr.4003.627. PMID 9210119.
8. ^ Hintze JM, Ludlow CL, Bansberg SF, Adler CH, Lott DG (October 2017). "Spasmodic Dysphonia: A Review. Part 1: Pathogenic Factors". Otolaryngology–Head and Neck Surgery. 157 (4): 551–557. doi:10.1177/0194599817728521. PMID 28850801. S2CID 3395208.
9. Murry T (November 2014). "Spasmodic dysphonia: let's look at that again". Journal of Voice. 28 (6): 694–9. doi:10.1016/j.jvoice.2014.03.007. PMID 24972536.
10. Childs L, Rickert S, Murry T, Blitzer A, Sulica L (October 2011). "Patient perceptions of factors leading to spasmodic dysphonia: a combined clinical experience of 350 patients". The Laryngoscope. 121 (10): 2195–8. doi:10.1002/lary.22168. PMID 21898448. S2CID 26651715.
11. Balint B, Bhatia KP (August 2014). "Dystonia: an update on phenomenology, classification, pathogenesis and treatment". Current Opinion in Neurology. 27 (4): 468–76. doi:10.1097/wco.0000000000000114. PMID 24978640.
12. ^ Lohmann K, Wilcox RA, Winkler S, Ramirez A, Rakovic A, Park JS, Arns B, Lohnau T, Groen J, Kasten M, Brüggemann N, Hagenah J, Schmidt A, Kaiser FJ, Kumar KR, Zschiedrich K, Alvarez-Fischer D, Altenmüller E, Ferbert A, Lang AE, Münchau A, Kostic V, Simonyan K, Agzarian M, Ozelius LJ, Langeveld AP, Sue CM, Tijssen MA, Klein C (April 2013). "Whispering dysphonia (DYT4 dystonia) is caused by a mutation in the TUBB4 gene". Annals of Neurology. 73 (4): 537–45. doi:10.1002/ana.23829. PMC 6956988. PMID 23595291.
13. Fuchs T, Gavarini S, Saunders-Pullman R, Raymond D, Ehrlich ME, Bressman SB, Ozelius LJ (March 2009). "Mutations in the THAP1 gene are responsible for DYT6 primary torsion dystonia". Nature Genetics. 41 (3): 286–8. doi:10.1038/ng.304. PMID 19182804. S2CID 205348799.
14. de Gusmão CM, Fuchs T, Moses A, Multhaupt-Buell T, Song PC, Ozelius LJ, Franco RA, Sharma N (October 2016). "Dystonia-Causing Mutations as a Contribution to the Etiology of Spasmodic Dysphonia". Otolaryngology–Head and Neck Surgery. 155 (4): 624–8. doi:10.1177/0194599816648293. PMC 5536965. PMID 27188707.
15. Sulica L (December 2004). "Contemporary management of spasmodic dysphonia". Current Opinion in Otolaryngology & Head and Neck Surgery. 12 (6): 543–8. doi:10.1097/01.moo.0000145959.50513.5e. PMID 15548915. S2CID 35757475.
16. Dystonias Fact Sheet: National Institute of Neurological Disorders and Stroke (NINDS) Archived 2006-12-05 at the Wayback Machine
17. ^ Kaye R, Blitzer A (November 2017). "Chemodenervation of the Larynx". Toxins. 9 (11): 356. doi:10.3390/toxins9110356. PMC 5705971. PMID 29099066.
18. Gündel H, Busch R, Ceballos-Baumann A, Seifert E (December 2007). "Psychiatric comorbidity in patients with spasmodic dysphonia: a controlled study". Journal of Neurology, Neurosurgery, and Psychiatry. 78 (12): 1398–400. doi:10.1136/jnnp.2007.121699. PMC 2095627. PMID 17615166.
19. ^ Newswise Medical News | Patients with Selected Voice Disorders Are Subject to Psychiatric Problems Archived 2008-08-02 at the Wayback Machine
20. Seifert E, Kollbrunner J (July 2005). "Stress and distress in non-organic voice disorder". Swiss Medical Weekly. 135 (27–28): 387–97. doi:10.4414/smw.2005.10346. PMID 16220409.
21. Ann Otol Rhinol Laryngol. 2001 Oct;110(10):941–5.
22. Spasmodic Dysphonia is a Neurological Disorder Current Evidence and References Archived 2011-02-06 at the Wayback Machine, by Christy L. Ludlow, Ph.D.
23. Merati AL, Heman-Ackah YD, Abaza M, Altman KW, Sulica L, Belamowicz S (November 2005). "Common movement disorders affecting the larynx: a report from the neurolaryngology committee of the AAO-HNS". Otolaryngology–Head and Neck Surgery. 133 (5): 654–65. doi:10.1016/j.otohns.2005.05.003. PMID 16274788. S2CID 39381849.
24. ^ Hintze JM, Ludlow CL, Bansberg SF, Adler CH, Lott DG (October 2017). "Spasmodic Dysphonia: A Review. Part 2: Characterization of Pathophysiology". Otolaryngology–Head and Neck Surgery. 157 (4): 558–564. doi:10.1177/0194599817728465. PMID 28850796. S2CID 19081873.
25. ^ Whurr R, Lorch M (June 2016). "Review of differential diagnosis and management of spasmodic dysphonia" (PDF). Current Opinion in Otolaryngology & Head and Neck Surgery. 24 (3): 203–7. doi:10.1097/MOO.0000000000000253. PMID 26900821. S2CID 43989350.
26. ^ "Spasmodic Dysphonia". www.asha.org. Retrieved 2017-11-05.
27. ^ Whurr R, Lorch M (June 2016). "Review of differential diagnosis and management of spasmodic dysphonia" (PDF). Current Opinion in Otolaryngology & Head and Neck Surgery. 24 (3): 203–7. doi:10.1097/MOO.0000000000000253. PMID 26900821. S2CID 43989350.
28. ^ Hintze JM, Ludlow CL, Bansberg SF, Adler CH, Lott DG (October 2017). "Spasmodic Dysphonia: A Review. Part 2: Characterization of Pathophysiology". Otolaryngology–Head and Neck Surgery. 157 (4): 558–564. doi:10.1177/0194599817728465. PMID 28850796. S2CID 19081873.
29. ^ Sulica L (December 2004). "Contemporary management of spasmodic dysphonia". Current Opinion in Otolaryngology & Head and Neck Surgery. 12 (6): 543–548. doi:10.1097/01.moo.0000145959.50513.5e. ISSN 1068-9508. PMID 15548915. S2CID 35757475.
30. Parker N (March 1985). "Hereditary whispering dysphonia". Journal of Neurology, Neurosurgery, and Psychiatry. 48 (3): 218–24. doi:10.1136/jnnp.48.3.218. PMC 1028253. PMID 3156966.
31. Woodson G, Hochstetler H, Murry T (March 2006). "Botulinum toxin therapy for abductor spasmodic dysphonia". Journal of Voice. 20 (1): 137–43. doi:10.1016/j.jvoice.2005.03.008. PMID 16126369.
32. ^ "Definition of Spasmodic dysphonia". MedTerms medical dictionary. MedicineNet.com. Archived from the original on 2007-09-27. Retrieved 2007-05-11.
33. ^ van Esch BF, Wegner I, Stegeman I, Grolman W (2017). "Effect of Botulinum Toxin and Surgery among Spasmodic Dysphonia Patients". Otolaryngology–Head and Neck Surgery. 156 (2): 238–254. doi:10.1177/0194599816675320. PMID 27803079. S2CID 4332852.
34. ^ "Spasmodic Dysphonia". Publication No. 10-4214. National Institute on Deafness and Other Communication Disorders. 2015-08-18. Retrieved 2016-07-09.Includes text taken directly from the website. As a work of the National Institutes of Health, part of the United States Department of Health and Human Services, this text constitutes a work of the U.S. federal government, therefore it is in the public domain.
35. ^ Ludlow CL (2009). "Treatment for spasmodic dysphonia: limitations of current approaches". Current Opinion in Otolaryngology & Head and Neck Surgery. 17 (3): 160–165. doi:10.1097/MOO.0b013e32832aef6f. PMC 2763389. PMID 19337127.
36. Grillone GA, Chan T (February 2006). "Laryngeal dystonia" (PDF). Otolaryngologic Clinics of North America. 39 (1): 87–100. doi:10.1016/j.otc.2005.11.001. PMID 16469657.
37. Watts C, Nye C, Whurr R (2006). "Botulinum toxin for treating spasmodic dysphonia (laryngeal dystonia): a systematic Cochrane review". Clinical Rehabilitation. 20 (2): 112–122. doi:10.1191/0269215506cr931oa. PMID 16541931. S2CID 34806668.
38. Watts CC, Whurr R, Nye C (2004). "Botulinum toxin injections for the treatment of spasmodic dysphonia". The Cochrane Database of Systematic Reviews. 2010 (3): CD004327. doi:10.1002/14651858.CD004327.pub2. ISSN 1469-493X. PMC 8805439. PMID 15266530.
39. Boutsen F, Cannito MP, Taylor M, Bender B (2002). "Botox Treatment in Adductor Spasmodic Dysphonia: A Meta-Analysis". Journal of Speech, Language, and Hearing Research. 45 (3): 469–481. doi:10.1044/1092-4388(2002/037). ISSN 1092-4388. PMID 12069000.
40. ^ Chhetri DK, Berke GS (February 2006). "Treatment of adductor spasmodic dysphonia with selective laryngeal adductor denervation and reinnervation surgery" (PDF). Otolaryngologic Clinics of North America. 39 (1): 101–9. doi:10.1016/j.otc.2005.10.005. PMID 16469658. Archived (PDF) from the original on 2012-05-31.
41. Warner TT, Bressman SB (2007-12-28). Clinical Diagnosis and Management of Dystonia. CRC Press. pp. 111–. ISBN 978-0-203-64048-7.
42. ^ Snow JB, Wackym PA (2009). Ballenger's otorhinolaryngology : head and neck surgery (17th ed.). Shelton, Conn.: People's Medical Pub. House/B C Decker. p. 918. ISBN 978-1-55009-337-7.
43. Stemple JC, Glaze LE, Klaben BG (2000). Clinical voice pathology : theory and management (3. ed.). San Diego, Calif.: Singular Publ. Group. p. 368. ISBN 978-0-7693-0005-4.
44. Ribeiro VV, Pedrosa V, Silverio KC, Behlau M (September 2018). "Laryngeal Manual Therapies for Behavioral Dysphonia: A Systematic Review and Meta-analysis". Journal of Voice. 32 (5): 553–563. doi:10.1016/j.jvoice.2017.06.019. PMID 28844806. S2CID 12535772.
45. Fahn S, Jankovic J, Hallett M (2011). Principles and Practice of Movement Disorders E-Book. Elsevier Health Sciences. p. 309. ISBN 978-1437737707.
46. ^ Rubin JS, Sataloff RT, Korovin GS (2014-05-01). Diagnosis and treatment of voice disorders (4th ed.). San Diego, CA: Plural Publishing. ISBN 978-1-597-56644-5. OCLC 885595880.
47. Traube L, Fränkel (1871). Gesammelte Beiträge zur Pathologie und Physiologie (in German). Hirschwald.
48. Schnitzler J (1895). Klinischer Atlas der Laryngologie nebst Anleitung zur Diagnose und Therapie der Krankeiten des Kehlkopfes und der Luftröhre (in German). W. Braumüller.
49. Gowers WR (1898). A Manual of Diseases of the Nervous System. P. Blakiston, Son & Company. p. 294.
50. ^ Aronson AE, Brown JR, Litin EM, Pearson JS (1968-08-01). "Spastic Dysphonia. II. Comparison with Essential (Voice) Tremor and Other Neurologic and Psychogenic Dysphonias". Journal of Speech and Hearing Disorders. 33 (3): 219–231. doi:10.1044/jshd.3303.219. ISSN 0022-4677. PMID 5668051.
51. Blitzer A, Brin MF, Simonyan K, Ozelius LJ, Frucht SJ (January 2018). "Phenomenology, Genetics and CNS network abnormalities in Laryngeal Dystonia: a 30 year experience". The Laryngoscope. 128 (Suppl 1): S1–S9. doi:10.1002/lary.27003. ISSN 0023-852X. PMC 5757628. PMID 29219190.
52. Dedo HH (1976). "Recurrent Laryngeal Nerve Section for Spastic Dysphonia". Annals of Otology, Rhinology & Laryngology. 85 (4): 451–459. doi:10.1177/000348947608500405. PMID 949152. S2CID 45456710.
53. "'Dilbert' creator recovers from rare disorder". NBC News. Associated Press. 2006-10-27. Archived from the original on 2013-12-20. Retrieved 2007-07-30.
54. Beal J (1998-04-29). "Golden country Johnny Bush hasn't run dry after almost 50 years of heartaches and honky-tonks". San Antonio Express-News.
55. The Voice Gallery - Thomas Allen Publishers - Thomas Allen & Son Limited Archived 2007-10-19 at the Wayback Machine
56. "The Voice Gallery: Travels with a Glass Throat | Quill and Quire". Quill and Quire. 21 January 2004. Retrieved 11 August 2018.
57. McHale L, Degginger C (May 14, 1999). "Chip Hanauer's restored voice gives him a new lease on life". University of Washington News and Information. Archived from the original on December 15, 2012. Retrieved September 22, 2012.
58. Hetrick A (August 1, 2017). "Actor Rodney Hicks Opens Up About Come From Away Departure". Playbill. Retrieved July 18, 2023.
59. ☆いつも応援してくれているファンの皆さんへ☆
60. Liebovich M (2006-06-25). "Another Kennedy Living Dangerously". The New York Times. Archived from the original on 2008-04-07. Retrieved 2007-07-30.
61. Sullivan J (2004-02-19). "Hello, Mary Lou – Goodbye, Heartache". Boston Globe.
62. "Benjamin Edward "Benny" Martin". Bluegrass Music Hall of Fame. 8 June 2018. Retrieved 2021-09-01.
63. Heffernan V (2006-02-25). "After the Hit Records, A Search for His Roots". The New York Times.
64. Clarke J. "The reason why '90s pop star Jenny Morris disappeared". Sydney Morning Herald. Archived from the original on 2015-10-11.
65. Australian Story (Series 2015; Episode 37) - Raise Your Voice, Australian Broadcasting Corporation (ABC). First aired Monday 12 October 2015.
66. Hollstein M (10 December 2012). "Als Petra Pau plötzlich ihre Stimme verlor" [When Petra Pau Suddenly Lost Her Voice]. Die Welt (in German). Berlin. ISSN 0173-8437.
67. Cannella G (26 July 2021). "How a CBS News correspondent's anxiety almost cost him his voice". Retrieved 23 November 2022.
68. Weeks L (August 23, 1999). "Diane Rehm Finds a Voice of Her Own". Washington Post. Retrieved May 2, 2019.
69. Introduction to Gail Strickland, May 2022, retrieved 2023-12-20
70. Price DE (March 13, 2013). "Audio Adrenaline Begin New Chapter With Pop-Tinged 'Kings & Queens'". Billboard. Retrieved March 23, 2019.
71. "Thompson's Trials: UK Folk Rock Great Makes Triumphant Return to the Stage". Tim Perlich, NOW Toronto. 2002-10-17. Archived from the original on 2007-09-29. Retrieved 2007-08-23.

External links

• Voice disorders